Skip to content
HeyJared

A Whisky with Charles

Welcome to ‘A Whisky with Charles,’ the personal Substack newsletter of financial analyst and private investor Charles Archer - aka @that_stocks_guy.

Newsletter · By Charles Archer · English · Official site

Indexed issues, last 90 days
26
Latest publication
Sep 29, 2026
Audience
Checking…
Earliest in this view
Aug 30, 2026

Latest issues

  1. Issue · Sep 29, 2026

    Time To Act (opens the original)

    Excerpt

    Read excerpt

    <img alt="" class="sizing-normal" height="608" src="https://substackcdn.com/image/fetch/$s_!OhK_!,w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F44b7c23e-9e62-43aa-a40d-a20d2fb5f9ec_1024x608.jpe

  2. Issue · Sep 28, 2026

    Atomic Metals (opens the original)

    Excerpt · Positive tone

    Read excerpt

    Good Morning Team.Please enjoy my conversation with Paul, tracing a career that spans more than two decades in the natural resources sector. Thanks for reading A Whisky with Charles! Subscribe for free to receive new posts and support my work.<div c

  3. Issue · Sep 28, 2026

    Asiamet Resources (opens the original)

    Excerpt

    Read excerpt

    <img alt="Diving in Gold - Disney Limited Edition by Rodel Gonzalez – Disney Art On Main Street" class="sizing-normal" height="1200" src="https://substackcdn.com/image/fetch/$s_!0029!,w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post

  4. Issue · Sep 27, 2026

    Prospex Energy (opens the original)

    Excerpt

    Read excerpt

    Good Evening Team.Please enjoy my chat with PXEN CEO Tom Reynolds.Thanks for reading A Whisky with Charles! Subscribe for free to receive new posts and support my work.We talked about Prospe

  5. Issue · Sep 27, 2026

    Poolbeg Pharma (opens the original)

    Excerpt · Positive tone

    Read excerpt

    Good Morning Team.PLease enjoy my chat with Cathal Friel about the company’s progress through 2026, opening with a simple framing of what Poolbeg is trying to achieve and reflecting on a milestone-heavy year — MHRA authorisation, the first patient dosed in the TOPICAL trial, a deepening relationship with J&J, and a steady run of patent grants. Thanks for reading A Whisky with Charles! Subscribe for free to receive new posts and support my work.<form class="subscriptio

Publishing over time

Last 90 days. Choose a month to open its work.

Recurring subjects

Named in the text we hold. One piece can cover several.

Audience

No verified audience measurement yet.

About this data

Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.

Identity or attribution wrong? Suggest a correction.

See coverage about A Whisky with Charles